T-cell recognition of chemicals, protein allergens and drugs

Towards the development of in vitro assays

Stefan F. Martin, Philipp R. Esser, Sonja Schmucker, Lisa Dietz, Dean J. Naisbitt, B. Kevin Park, Marc Vocanson, Jean Francois Nicolas, Monika Keller, Werner J. Pichler, Matthias Peiser, Andreas Luch, Reinhard Wanner, Enrico Maggi, Andrea Cavani, Thomas Rustemeyer, Anne Richter, Hermann Josef Thierse, Federica Sallusto

Research output: Contribution to journalArticle

99 Citations (Scopus)

Abstract

Chemicals can elicit T-cell-mediated diseases such as allergic contact dermatitis and adverse drug reactions. Therefore, testing of chemicals, drugs and protein allergens for hazard identification and risk assessment is essential in regulatory toxicology. The seventh amendment of the EU Cosmetics Directive now prohibits the testing of cosmetic ingredients in mice, guinea pigs and other animal species to assess their sensitizing potential. In addition, the EU Chemicals Directive REACh requires the retesting of more than 30,000 chemicals for different toxicological endpoints, including sensitization, requiring vast numbers of animals. Therefore, alternative methods are urgently needed to eventually replace animal testing. Here, we summarize the outcome of an expert meeting in Rome on 7 November 2009 on the development of T-cell-based in vitro assays as tools in immunotoxicology to identify hazardous chemicals and drugs. In addition, we provide an overview of the development of the field over the last two decades.

Original languageEnglish
Pages (from-to)4171-4184
Number of pages14
JournalCellular and Molecular Life Sciences
Volume67
Issue number24
DOIs
Publication statusPublished - Dec 2010

Fingerprint

Allergens
T-Lymphocytes
Cosmetics
Toxicology
Pharmaceutical Preparations
Hazardous Substances
Proteins
Allergic Contact Dermatitis
Drug-Related Side Effects and Adverse Reactions
Guinea Pigs
In Vitro Techniques
Haemophilus influenzae type b-polysaccharide vaccine-diphtheria toxoid conjugate

Keywords

  • Allergy
  • Bioassay
  • Contact dermatitis
  • Drug hypersensitivity
  • Immunotoxicology
  • In vitro alternatives
  • Non-animal testing
  • T cell

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology
  • Molecular Medicine
  • Pharmacology
  • Cellular and Molecular Neuroscience

Cite this

Martin, S. F., Esser, P. R., Schmucker, S., Dietz, L., Naisbitt, D. J., Park, B. K., ... Sallusto, F. (2010). T-cell recognition of chemicals, protein allergens and drugs: Towards the development of in vitro assays. Cellular and Molecular Life Sciences, 67(24), 4171-4184. https://doi.org/10.1007/s00018-010-0495-3

T-cell recognition of chemicals, protein allergens and drugs : Towards the development of in vitro assays. / Martin, Stefan F.; Esser, Philipp R.; Schmucker, Sonja; Dietz, Lisa; Naisbitt, Dean J.; Park, B. Kevin; Vocanson, Marc; Nicolas, Jean Francois; Keller, Monika; Pichler, Werner J.; Peiser, Matthias; Luch, Andreas; Wanner, Reinhard; Maggi, Enrico; Cavani, Andrea; Rustemeyer, Thomas; Richter, Anne; Thierse, Hermann Josef; Sallusto, Federica.

In: Cellular and Molecular Life Sciences, Vol. 67, No. 24, 12.2010, p. 4171-4184.

Research output: Contribution to journalArticle

Martin, SF, Esser, PR, Schmucker, S, Dietz, L, Naisbitt, DJ, Park, BK, Vocanson, M, Nicolas, JF, Keller, M, Pichler, WJ, Peiser, M, Luch, A, Wanner, R, Maggi, E, Cavani, A, Rustemeyer, T, Richter, A, Thierse, HJ & Sallusto, F 2010, 'T-cell recognition of chemicals, protein allergens and drugs: Towards the development of in vitro assays', Cellular and Molecular Life Sciences, vol. 67, no. 24, pp. 4171-4184. https://doi.org/10.1007/s00018-010-0495-3
Martin, Stefan F. ; Esser, Philipp R. ; Schmucker, Sonja ; Dietz, Lisa ; Naisbitt, Dean J. ; Park, B. Kevin ; Vocanson, Marc ; Nicolas, Jean Francois ; Keller, Monika ; Pichler, Werner J. ; Peiser, Matthias ; Luch, Andreas ; Wanner, Reinhard ; Maggi, Enrico ; Cavani, Andrea ; Rustemeyer, Thomas ; Richter, Anne ; Thierse, Hermann Josef ; Sallusto, Federica. / T-cell recognition of chemicals, protein allergens and drugs : Towards the development of in vitro assays. In: Cellular and Molecular Life Sciences. 2010 ; Vol. 67, No. 24. pp. 4171-4184.
@article{34a0f2b269d5471f9840506d9f3344f6,
title = "T-cell recognition of chemicals, protein allergens and drugs: Towards the development of in vitro assays",
abstract = "Chemicals can elicit T-cell-mediated diseases such as allergic contact dermatitis and adverse drug reactions. Therefore, testing of chemicals, drugs and protein allergens for hazard identification and risk assessment is essential in regulatory toxicology. The seventh amendment of the EU Cosmetics Directive now prohibits the testing of cosmetic ingredients in mice, guinea pigs and other animal species to assess their sensitizing potential. In addition, the EU Chemicals Directive REACh requires the retesting of more than 30,000 chemicals for different toxicological endpoints, including sensitization, requiring vast numbers of animals. Therefore, alternative methods are urgently needed to eventually replace animal testing. Here, we summarize the outcome of an expert meeting in Rome on 7 November 2009 on the development of T-cell-based in vitro assays as tools in immunotoxicology to identify hazardous chemicals and drugs. In addition, we provide an overview of the development of the field over the last two decades.",
keywords = "Allergy, Bioassay, Contact dermatitis, Drug hypersensitivity, Immunotoxicology, In vitro alternatives, Non-animal testing, T cell",
author = "Martin, {Stefan F.} and Esser, {Philipp R.} and Sonja Schmucker and Lisa Dietz and Naisbitt, {Dean J.} and Park, {B. Kevin} and Marc Vocanson and Nicolas, {Jean Francois} and Monika Keller and Pichler, {Werner J.} and Matthias Peiser and Andreas Luch and Reinhard Wanner and Enrico Maggi and Andrea Cavani and Thomas Rustemeyer and Anne Richter and Thierse, {Hermann Josef} and Federica Sallusto",
year = "2010",
month = "12",
doi = "10.1007/s00018-010-0495-3",
language = "English",
volume = "67",
pages = "4171--4184",
journal = "Cellular and Molecular Life Sciences",
issn = "1420-682X",
publisher = "Birkhauser Verlag Basel",
number = "24",

}

TY - JOUR

T1 - T-cell recognition of chemicals, protein allergens and drugs

T2 - Towards the development of in vitro assays

AU - Martin, Stefan F.

AU - Esser, Philipp R.

AU - Schmucker, Sonja

AU - Dietz, Lisa

AU - Naisbitt, Dean J.

AU - Park, B. Kevin

AU - Vocanson, Marc

AU - Nicolas, Jean Francois

AU - Keller, Monika

AU - Pichler, Werner J.

AU - Peiser, Matthias

AU - Luch, Andreas

AU - Wanner, Reinhard

AU - Maggi, Enrico

AU - Cavani, Andrea

AU - Rustemeyer, Thomas

AU - Richter, Anne

AU - Thierse, Hermann Josef

AU - Sallusto, Federica

PY - 2010/12

Y1 - 2010/12

N2 - Chemicals can elicit T-cell-mediated diseases such as allergic contact dermatitis and adverse drug reactions. Therefore, testing of chemicals, drugs and protein allergens for hazard identification and risk assessment is essential in regulatory toxicology. The seventh amendment of the EU Cosmetics Directive now prohibits the testing of cosmetic ingredients in mice, guinea pigs and other animal species to assess their sensitizing potential. In addition, the EU Chemicals Directive REACh requires the retesting of more than 30,000 chemicals for different toxicological endpoints, including sensitization, requiring vast numbers of animals. Therefore, alternative methods are urgently needed to eventually replace animal testing. Here, we summarize the outcome of an expert meeting in Rome on 7 November 2009 on the development of T-cell-based in vitro assays as tools in immunotoxicology to identify hazardous chemicals and drugs. In addition, we provide an overview of the development of the field over the last two decades.

AB - Chemicals can elicit T-cell-mediated diseases such as allergic contact dermatitis and adverse drug reactions. Therefore, testing of chemicals, drugs and protein allergens for hazard identification and risk assessment is essential in regulatory toxicology. The seventh amendment of the EU Cosmetics Directive now prohibits the testing of cosmetic ingredients in mice, guinea pigs and other animal species to assess their sensitizing potential. In addition, the EU Chemicals Directive REACh requires the retesting of more than 30,000 chemicals for different toxicological endpoints, including sensitization, requiring vast numbers of animals. Therefore, alternative methods are urgently needed to eventually replace animal testing. Here, we summarize the outcome of an expert meeting in Rome on 7 November 2009 on the development of T-cell-based in vitro assays as tools in immunotoxicology to identify hazardous chemicals and drugs. In addition, we provide an overview of the development of the field over the last two decades.

KW - Allergy

KW - Bioassay

KW - Contact dermatitis

KW - Drug hypersensitivity

KW - Immunotoxicology

KW - In vitro alternatives

KW - Non-animal testing

KW - T cell

UR - http://www.scopus.com/inward/record.url?scp=78651328041&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78651328041&partnerID=8YFLogxK

U2 - 10.1007/s00018-010-0495-3

DO - 10.1007/s00018-010-0495-3

M3 - Article

VL - 67

SP - 4171

EP - 4184

JO - Cellular and Molecular Life Sciences

JF - Cellular and Molecular Life Sciences

SN - 1420-682X

IS - 24

ER -